Viewpoint Capital Management’s Sana Biotechnology SANA Stock Holding History

Viewpoint Capital Management’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$82.2K	Hold	23,545	–	–	0.04%	106
2026 Q1	$67.8K	Hold	23,545	–	–	0.03%	113
2025 Q4	$95.8K	Hold	23,545	–	–	0.04%	111
2025 Q3	$83.6K	Sell	23,545 -4,500	-16%	-$16.3K	0.04%	117
2025 Q2	$76.6K	Buy	28,045 +4,500	+19%	+$9.28K	0.04%	114
2025 Q1	$39.6K	Hold	23,545	–	–	0.02%	122
2024 Q4	$38.4K	Hold	23,545	–	–	0.02%	118
2024 Q3	$101K	Hold	23,545	–	–	0.06%	113
2024 Q2	$129K	Hold	23,545	–	–	0.08%	106
2024 Q1	$235K	Hold	23,545	–	–	0.15%	93
2023 Q4	$96.1K	Hold	23,545	–	–	0.07%	109
2023 Q3	$91.1K	Hold	23,545	–	–	0.07%	102
2023 Q2	$140K	Hold	23,545	–	–	0.11%	94
2023 Q1	$77K	Hold	23,545	–	–	0.07%	96
2022 Q4	$93K	Hold	23,545	–	–	0.09%	90
2022 Q3	$141K	Hold	23,545	–	–	0.14%	82
2022 Q2	$151K	Buy	+23,545	New	+$150K	0.14%	85

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Viewpoint Capital Management's SANA Position: Q2 2026 in Review

Viewpoint Capital Management held its Sana Biotechnology (SANA) position steady in Q2 2026 at 23,545 shares worth $82.2K. The position accounts for 0.04% of the portfolio, ranked #106.

Viewpoint Capital Management first reported a position in SANA in Q2 2022 and has held it in 17 quarters since. The position peaked at $235K in Q1 2024. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Viewpoint Capital Management held 23,545 shares of Sana Biotechnology worth $82.2K as of Q2 2026.
Viewpoint Capital Management left its Sana Biotechnology share count unchanged in Q2 2026.
Sana Biotechnology made up 0.04% of Viewpoint Capital Management's portfolio in Q2 2026, its #106 holding.
Viewpoint Capital Management first reported a position in Sana Biotechnology in Q2 2022 and has held it in 17 quarters since.
Viewpoint Capital Management's Sana Biotechnology position peaked at $235K in Q1 2024.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Viewpoint Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.